Bowles Robert D, Setton Lori A
Department of Bioengineering, University of Utah, Salt Lake City, UT 84112, USA.
Department of Biomedical Engineering & Orthopedic Surgery, Washington University in St. Louis, St. Louis, MO 63130, USA.
Biomaterials. 2017 Jun;129:54-67. doi: 10.1016/j.biomaterials.2017.03.013. Epub 2017 Mar 15.
The intervertebral disc contributes to motion, weight bearing, and flexibility of the spine, but is susceptible to damage and morphological changes that contribute to pathology with age and injury. Engineering strategies that rely upon synthetic materials or composite implants that do not interface with the biological components of the disc have not met with widespread use or desirable outcomes in the treatment of intervertebral disc pathology. Here we review bioengineering advances to treat disc disorders, using cell-supplemented materials, or acellular, biologically based materials, that provide opportunity for cell-material interactions and remodeling in the treatment of intervertebral disc disorders. While a field still in early development, bioengineering-based strategies employing novel biomaterials are emerging as promising alternatives for clinical treatment of intervertebral disc disorders.
椎间盘有助于脊柱的运动、负重和灵活性,但随着年龄增长和损伤,它易受到损害并发生形态变化,进而导致病变。依靠合成材料或与椎间盘生物成分无界面的复合植入物的工程策略,在椎间盘病变治疗中尚未得到广泛应用或取得理想效果。在此,我们综述了治疗椎间盘疾病的生物工程进展,这些进展使用了补充细胞的材料或无细胞的生物基材料,为椎间盘疾病治疗中的细胞-材料相互作用和重塑提供了机会。虽然这一领域仍处于早期发展阶段,但采用新型生物材料的基于生物工程的策略正成为治疗椎间盘疾病的有前景的替代方法。